Business Development Deal Architecture
  • Search OnBioBD:

  • OnBioBD OldSkool NEWS:

    - OnBioVC 4Q11 Trend Analysis, now available
    - OnBioVC 1Q12 White Paper, now available
    - OnBioVC 1Q12 Trend Analysis, coming soon

  • FDA Registered Contract Manufacturer

Apnex Medical (St Paul, MN) a clinical-stage medical device company focused on implantable treatments for sleep apnea, closed a $20M Series C financing. Participants include Domain Associates, New Enterprise Associates and Polaris Venture Partners.

MedVentive (Waltham, MA) a commercial-stage electronic medical data company focused on clinical integration, population management and financial risk management, closed a $12M Series D financing. Participants include National Healthcare Services, CHV Capital, Core Capital Partners, Excel Venture Management, HLM Venture Partners and Long River Ventures.

PharmaSecure (Lebanon, NH) a commercial-stage pharmaceutical product security company focused on drug authentication technologies, closed $3.9M Series B financing. Participants include Innovation Endeavors, Gray Ghost Ventures, Healthtech Capital and the Teec Angel Fund.

Dermira (Redwood City, CA) a clinical-stage pharmaceutical company focused on topical treatments and light therapy for acne and inflammatory skin disease, closed a $42M Series A financing. Participants include Bay City Capital, New Enterprise Associates and Canaan Partners.

Cleave Biosciences (Burlingame, CA) a preclinical-stage pharmaceutical company focused on small molecules for oncology, closed a $42M Series A financing. Participants include US Venture Partners, 5AM Ventures, Clarus Ventures, OrbiMed Advisors and Astellas Venture Management.

Firefly BioWorks (Cambridge, MA) a development-stage biotechnologycompany focused on an open platform multiplexed biological assay standardization for the quantification of biological function, closed a $2M Series A financing. Participants were not identified.

OvaScience (Boston, MA) a development-stage biotechnology company focused on mitochondria rejuvenation to improve fertility, closed a Series A financing. Participants include Bessemer Venture Partners and Longwood Founders Fund.

Arteaus Therapeutics (Cambridge, MA) a development-stage biopharmaceutical company focused on antibody treatment for the prevention of migraine headache, closed a $18M Series A financing. Participants include Atlas Venture and OrbiMed.

100Plus (San Francisco, CA) a development-stage personalized health applications company focused on behavior modifications, closed a $1.3M Series A financing. Participants include Founders Fund, Greylock Partners and Band of Angels.

EndoEvolution (North Chelmsford, MA) a development-stage medical device company focused on minimally invasive surgery and automated suturing devices, closed a $3.3M Series B financing. Participants include Spring Bay Companies.

Creabilis (Luxembourg) a clinical-stage biotechnology company focused dermatology and inflammatory diseases, closed a $20M Series B financing. Participants include Abbott Biotech Ventures, Neomed and Sofinnova Partners.

Arsenal Medical (Watertown, MA) a development-stage biotech company focused on nanofiber drug delivery and therapeutic foams to accommodate complex anatomies,closed $3M Series A financing. Participants include Polaris Venture Partners, North Bridge Venture Partners and Intersouth Partners.

Azelon Pharmaceuticals (West Conshohocken, PA) a preclinical-stage pharmaceutical company focused on osteoporosis, closed a $4.5M Series A financing. Participants include Prospect Venture Partners, Lighthouse Capital Partners and Covington Venture Fund.

« Previous Entries  Next Page »

to top of page...